348
Participants
Start Date
September 30, 1992
Primary Completion Date
November 30, 2000
Study Completion Date
April 30, 2014
doxorubicin hydrochloride
25 mg/m\^2 on days 1 and 15
vinblastine
6 mg/m\^2 on days 1 and 15
standard subtotal nodal irradiation
3600-4000 cGy delivered over 20 fractions
Mount Sinai Medical Center, NY, New York
CCOP - North Shore University Hospital, Manhasset
State University of New York - Upstate Medical University, Syracuse
CCOP - Christiana Care Health Services, Wilmington
CCOP - Mount Sinai Medical Center, Miami Beach
University of Tennessee, Memphis Cancer Center, Memphis
University of Iowa Hospitals and Clinics, Iowa City
University of Minnesota Cancer Center, Minneapolis
University of Chicago Cancer Research Center, Chicago
Barnes-Jewish Hospital, St Louis
Ellis Fischel Cancer Center - Columbia, Columbia
CCOP - Southern Nevada Cancer Research Foundation, Las Vegas
University of California San Diego Cancer Center, La Jolla
Walter Reed Army Medical Center, Washington D.C.
University of Massachusetts Memorial Medical Center, Worcester
Norris Cotton Cancer Center, Lebanon
Roswell Park Cancer Institute, Buffalo
CCOP - Southeast Cancer Control Consortium, Winston-Salem
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem
Rhode Island Hospital, Providence
Vermont Cancer Center, Burlington
MBCCOP - Massey Cancer Center, Richmond
National Cancer Institute (NCI)
NIH
Cancer and Leukemia Group B
NETWORK
SWOG Cancer Research Network
NETWORK